Zhejiang Huahai Pharmaceutical Co Ltd, based in China, is a pharmaceutical company that stands out with its certifications from FDA and EDQM.
One of their notable products is TOPIRAMATE, with a corresponding US DMF Number 28371.
Remarkably, this DMF maintains an Active status since its submission on June 16, 2014, highlighting commitment to regulatory compliance.
Their GDUFA DMF Review was successfully complete, with a review date of October 10, 2014, and payment made on July 01, 2014, indicating their dedication to facilitating drug approvals, Categorized as Type II